FDA Clinical Outcome Assessments and CDISC QRS supplements: Enabling Patient Centric Drug Development Second Edition

Preise von
47,75

Hervorgehoben


Beschreibung

Amazon FDA Clinical Outcome Assessments and CDISC QRS supplements: Enabling Patient-Centric Drug Development Second Edition

Webshops vergleichen (1)

Shop
Preis
Versandkosten
Total price
47,75 
Gratis
47,75 
Zum Shop
Gratis Shipping Costs
Beschreibung (1)

FDA Clinical Outcome Assessments and CDISC QRS supplements: Enabling Patient-Centric Drug Development Second Edition


Produktspezifikationen

Marken LAP LAMBERT Academic Publishing
EAN
  • 9786209608780

Preise zuletzt aktualisiert am:

Hervorgehobene Wahl
47,75 
Zum Shop